Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Interest Expense

Amphastar Pharmaceuticals, Inc. Interest Expense

Amphastar Pharmaceuticals, Inc. (AMPH) reported Interest Expense of $8.61 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2024-05-10

  • Amphastar Pharmaceuticals, Inc. interest expense for the quarter ending 2024-03-31 was $8.61M, a 2063.57% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. interest expense for the quarter ending 2023-12-31 was $9.46M, a 1690.91% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. interest expense for the quarter ending 2023-09-30 was $13.70M, a 2320.85% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. interest expense for the quarter ending 2023-06-30 was $3.60M, a 807.30% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. interest expense for fiscal 2023 was $27.16M, a 1371.18% increase from fiscal 2022.
  • Amphastar Pharmaceuticals, Inc. interest expense for fiscal 2022 was $1.85M, a 108.59% increase from fiscal 2021.
  • Amphastar Pharmaceuticals, Inc. interest expense for fiscal 2021 was $885.00K, a 136.63% increase from fiscal 2020.
  • Amphastar Pharmaceuticals, Inc. interest expense for fiscal 2020 was $374.00K, a 214.29% increase from fiscal 2019.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2024-03-31$8.61M
10-Q · filed 2024-05-10
$18.07M
derived: sum of 2 quarters · filed 2024-05-10
$31.77M
derived: sum of 3 quarters · filed 2024-05-10
$35.37M
derived: sum of 4 quarters · filed 2024-05-10
2023-12-31$9.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$23.16M
derived: sum of 2 quarters · filed 2024-02-29
$26.76M
derived: sum of 3 quarters · filed 2024-02-29
$27.16M
10-K · filed 2024-02-29
2023-09-30$13.70M
10-Q · filed 2023-11-08
$17.30M
derived: sum of 2 quarters · filed 2023-11-08
$17.70M
10-Q · filed 2023-11-08
$18.23M
derived: sum of 4 quarters · filed 2024-05-10
2023-06-30$3.60M
10-Q · filed 2023-08-09
$4.00M
10-Q · filed 2023-08-09
$4.53M
derived: sum of 3 quarters · filed 2024-05-10
$5.09M
derived: sum of 4 quarters · filed 2024-05-10
2023-03-31$398.00K
10-Q · filed 2024-05-10
$926.00K
derived: sum of 2 quarters · filed 2024-05-10
$1.49M
derived: sum of 3 quarters · filed 2024-05-10
$1.89M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$1.09M
derived: sum of 2 quarters · filed 2024-02-29
$1.49M
derived: sum of 3 quarters · filed 2024-02-29
$1.85M
10-K · filed 2024-02-29
2022-09-30$566.00K
10-Q · filed 2023-11-08
$963.00K
derived: sum of 2 quarters · filed 2023-11-08
$1.32M
10-Q · filed 2023-11-08
$1.49M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$397.00K
10-Q · filed 2023-08-09
$752.00K
10-Q · filed 2023-08-09
$920.00K
derived: sum of 3 quarters · filed 2024-02-29
$1.45M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$355.00K
10-Q · filed 2023-05-09
$523.00K
derived: sum of 2 quarters · filed 2024-02-29
$1.05M
derived: sum of 3 quarters · filed 2024-02-29
$1.14M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$695.00K
derived: sum of 2 quarters · filed 2024-02-29
$781.00K
derived: sum of 3 quarters · filed 2024-02-29
$885.00K
10-K · filed 2024-02-29
2021-09-30$527.00K
10-Q · filed 2022-11-08
$613.00K
derived: sum of 2 quarters · filed 2022-11-08
$717.00K
10-Q · filed 2022-11-08
$805.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$86.00K
10-Q · filed 2022-08-09
$190.00K
10-Q · filed 2022-08-09
$278.00K
derived: sum of 3 quarters · filed 2023-03-01
$453.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$104.00K
10-Q · filed 2022-05-10
$192.00K
derived: sum of 2 quarters · filed 2023-03-01
$367.00K
derived: sum of 3 quarters · filed 2023-03-01
$402.00K
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$88.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$263.00K
derived: sum of 2 quarters · filed 2023-03-01
$298.00K
derived: sum of 3 quarters · filed 2023-03-01
$374.00K
10-K · filed 2023-03-01
2020-09-30$175.00K
10-Q · filed 2021-11-09
$210.00K
derived: sum of 2 quarters · filed 2021-11-09
$286.00K
10-Q · filed 2021-11-09
$329.00K
derived: sum of 4 quarters · filed 2022-03-11
2020-06-30$35.00K
10-Q · filed 2021-08-09
$111.00K
10-Q · filed 2021-08-09
$154.00K
derived: sum of 3 quarters · filed 2022-03-11
$176.00K
derived: sum of 4 quarters · filed 2022-03-11
2020-03-31$76.00K
10-Q · filed 2021-05-07
$119.00K
derived: sum of 2 quarters · filed 2022-03-11
$141.00K
derived: sum of 3 quarters · filed 2022-03-11
$165.00K
derived: sum of 4 quarters · filed 2022-03-11
2019-12-31$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$65.00K
derived: sum of 2 quarters · filed 2022-03-11
$89.00K
derived: sum of 3 quarters · filed 2022-03-11
$119.00K
10-K · filed 2022-03-11
2019-09-30$22.00K
10-Q · filed 2020-11-06
$46.00K
derived: sum of 2 quarters · filed 2020-11-06
$76.00K
10-Q · filed 2020-11-06
$77.00K
derived: sum of 4 quarters · filed 2021-03-15
2019-06-30$24.00K
10-Q · filed 2020-08-07
$54.00K
10-Q · filed 2020-08-07
$55.00K
derived: sum of 3 quarters · filed 2021-03-15
$179.00K
derived: sum of 4 quarters · filed 2021-03-15
2019-03-31$30.00K
10-Q · filed 2020-05-11
$31.00K
derived: sum of 2 quarters · filed 2021-03-15
$155.00K
derived: sum of 3 quarters · filed 2021-03-15
$255.00K
derived: sum of 4 quarters · filed 2021-03-15
2018-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
$125.00K
derived: sum of 2 quarters · filed 2021-03-15
$225.00K
derived: sum of 3 quarters · filed 2021-03-15
$243.00K
10-K · filed 2021-03-15
2018-09-30$124.00K
10-Q · filed 2019-11-08
$224.00K
derived: sum of 2 quarters · filed 2019-11-08
$242.00K
10-Q · filed 2019-11-08
$376.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$100.00K
10-Q · filed 2019-08-09
$118.00K
10-Q · filed 2019-08-09
$252.00K
derived: sum of 3 quarters · filed 2020-03-16
$516.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$18.00K
10-Q · filed 2019-05-10
$152.00K
derived: sum of 2 quarters · filed 2020-03-16
$416.00K
derived: sum of 3 quarters · filed 2020-03-16
$653.00K
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$398.00K
derived: sum of 2 quarters · filed 2020-03-16
$635.00K
derived: sum of 3 quarters · filed 2020-03-16
$826.00K
10-K · filed 2020-03-16
2017-09-30$264.00K
10-Q · filed 2018-11-09
$501.00K
derived: sum of 2 quarters · filed 2018-11-09
$692.00K
10-Q · filed 2018-11-09
$746.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$237.00K
10-Q · filed 2018-08-09
$428.00K
10-Q · filed 2018-08-09
$482.00K
derived: sum of 3 quarters · filed 2019-03-15
$763.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$191.00K
10-Q · filed 2018-05-10
$245.00K
derived: sum of 2 quarters · filed 2019-03-15
$526.00K
derived: sum of 3 quarters · filed 2019-03-15
$831.00K
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$335.00K
derived: sum of 2 quarters · filed 2019-03-15
$640.00K
derived: sum of 3 quarters · filed 2019-03-15
$1.02M
10-K · filed 2019-03-15
2016-09-30$281.00K
10-Q · filed 2017-11-09
$586.00K
derived: sum of 2 quarters · filed 2017-11-09
$970.00K
10-Q · filed 2017-11-09
$1.17M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$305.00K
10-Q · filed 2017-08-09
$689.00K
10-Q · filed 2017-08-09
$893.00K
derived: sum of 3 quarters · filed 2018-03-14
$1.13M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$384.00K
10-Q · filed 2017-05-10
$588.00K
derived: sum of 2 quarters · filed 2018-03-14
$820.00K
derived: sum of 3 quarters · filed 2018-03-14
$1.03M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$204.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$436.00K
derived: sum of 2 quarters · filed 2018-03-14
$646.00K
derived: sum of 3 quarters · filed 2018-03-14
$987.00K
10-K · filed 2018-03-14
2015-09-30$232.00K
10-Q · filed 2016-11-09
$442.00K
derived: sum of 2 quarters · filed 2016-11-09
$783.00K
10-Q · filed 2016-11-09
$233.00K
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$210.00K
10-Q · filed 2016-08-09
$551.00K
10-Q · filed 2016-08-09
$1.00K
derived: sum of 3 quarters · filed 2017-03-15
$505.00K
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$341.00K
10-Q · filed 2016-05-10
-$209.00K
derived: sum of 2 quarters · filed 2017-03-15
$295.00K
derived: sum of 3 quarters · filed 2017-03-15
$771.00K
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$550.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$46.00K
derived: sum of 2 quarters · filed 2017-03-15
$430.00K
derived: sum of 3 quarters · filed 2017-03-15
$609.00K
10-K · filed 2017-03-15
2014-09-30$504.00K
10-Q · filed 2015-11-13
$980.00K
derived: sum of 2 quarters · filed 2015-11-13
$1.16M
10-Q · filed 2015-11-13
$1.38M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$476.00K
10-Q · filed 2015-08-13
$655.00K
10-Q · filed 2015-08-13
$877.00K
derived: sum of 3 quarters · filed 2016-03-15
$1.07M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$180.00K
10-Q · filed 2015-05-14
$401.00K
derived: sum of 2 quarters · filed 2016-03-15
$596.00K
derived: sum of 3 quarters · filed 2016-03-15
$833.00K
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$221.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$416.00K
derived: sum of 2 quarters · filed 2016-03-15
$653.00K
derived: sum of 3 quarters · filed 2016-03-15
$958.00K
10-K · filed 2016-03-15
2013-09-30$195.00K
10-Q · filed 2014-11-13
$432.00K
derived: sum of 2 quarters · filed 2014-11-13
$737.00K
10-Q · filed 2014-11-13
2013-06-30$237.00K
10-Q · filed 2014-08-13
$542.00K
10-Q · filed 2014-08-13
2012-12-31$784.00K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87